Latest Capital Raises News

Resouro Strategic Metals launches a CAD 2 million private placement to fund engineering work advancing its Tiros project in Brazil, marking a key step toward a Preliminary Economic Assessment.

HMC Capital reported a robust FY25 with a 51% rise in operating EPS and a 47% jump in assets under management to $18.7 billion, driven by expansion across multiple funds management divisions.

Lake Resources N.L. has had its trading suspension lifted following the release of a capital raising announcement, signaling renewed market activity for the lithium explorer.

Lake Resources has tapped its At-the-Market facility to raise A$1.575 million, aiming to fund key development stages of its flagship Kachi lithium project in Argentina.

Lake Resources has successfully raised up to A$12 million through a strongly supported placement, bolstering its financial position to advance the Kachi lithium project in Argentina.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

Mount Burgess Mining has acquired two promising gold projects in Western Australia, Viking and Blair North, with plans to commence drilling in late 2025. The acquisitions come with strong historical drill results and a $900,000 capital raise to fund exploration.

Mount Burgess Mining NL has inked binding agreements to acquire two promising high-grade gold projects in Western Australia, setting the stage for exploration drilling in late 2025 backed by a $900,000 capital raise.

FBR Limited invites eligible shareholders to participate in a $1 million Share Purchase Plan at a 23.1% discount, aiming to fund key robotic projects and repay debt.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

betr Entertainment Limited has launched a superior all-scrip takeover offer for PointsBet Holdings Limited, valuing PointsBet shares between $1.22 and $1.29 each and aiming to create Australia’s fourth largest online wagering operator. The deal promises substantial cost synergies and strategic growth opportunities.